Published in Arterioscler Thromb Vasc Biol on March 01, 2005
Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr (2007) 1.24
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males. Proc Natl Acad Sci U S A (2007) 0.92
Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers. Am J Physiol Renal Physiol (2011) 0.87
PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflugers Arch (2008) 0.83
Coupling blood flow and neural function in the retina: a model for homeostatic responses to ocular perfusion pressure challenge. Physiol Rep (2013) 0.79
Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. PLoS One (2015) 0.78
Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury. J Neurotrauma (2011) 0.78
Refinement of telemetry for measuring blood pressure in conscious rats. J Am Assoc Lab Anim Sci (2009) 0.78
Kidney-Specific Reduction of Oxidative Phosphorylation Genes Derived from Spontaneously Hypertensive Rat. PLoS One (2015) 0.75
Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry. J Vis Exp (2016) 0.75
Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler Thromb Vasc Biol (2005) 1.82
Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet (2005) 7.82
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res (2004) 4.12
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension (2004) 3.51
Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res (2002) 3.29
Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol (2010) 3.25
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) (2005) 2.86
How to review a paper. Adv Physiol Educ (2003) 2.67
NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal (2006) 2.56
Hypertension and cerebrovascular dysfunction. Cell Metab (2008) 2.30
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation (2003) 2.22
Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res (2004) 1.98
Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (2008) 1.98
Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension (2003) 1.86
Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension (2004) 1.83
Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler Thromb Vasc Biol (2005) 1.82
Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res (2002) 1.81
Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (2006) 1.80
Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res (2008) 1.75
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis. Hypertension (2006) 1.74
Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain. Physiol Genomics (2004) 1.74
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (2005) 1.72
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (2003) 1.71
Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension (2011) 1.71
Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem (2010) 1.68
Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol (2004) 1.68
Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet (2008) 1.67
Protective importance of the myogenic response in the renal circulation. Hypertension (2009) 1.67
Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease. Diabetes Care (2004) 1.65
Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (2002) 1.63
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics (2006) 1.57
Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest (2007) 1.56
Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same? J Hypertens (2008) 1.55
ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. J Clin Invest (2012) 1.51
Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension (2005) 1.50
Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol (2004) 1.46
Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension (2009) 1.45
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol (2006) 1.44
Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circ Res (2013) 1.42
Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension (2002) 1.40
Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep (2006) 1.40
Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (2004) 1.39
Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res (2003) 1.37
Pathophysiology and treatment of obesity hypertension. Curr Pharm Des (2004) 1.37
CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages. J Infect Dis (2004) 1.36
Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension (2012) 1.33
Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens (2013) 1.32
Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia. Hypertension (2008) 1.31
Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (2011) 1.30
The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep (2009) 1.29
Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension (2004) 1.29
Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Clin J Am Soc Nephrol (2006) 1.28
Racial and ethnic differences in blood pressure: biology and sociology. Circulation (2006) 1.27
Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension (2002) 1.27
Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem (2011) 1.26
The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol (2010) 1.24
Genetic ablation of angiotensinogen in the subfornical organ of the brain prevents the central angiotensinergic pressor response. Circ Res (2006) 1.20
A differential role for endocytosis in receptor-mediated activation of Nox1. Antioxid Redox Signal (2010) 1.20
Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat Genet (2008) 1.19
Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol (2006) 1.18
Hypertensive renal damage: insights from animal models and clinical relevance. Curr Hypertens Rep (2004) 1.17
Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension (2003) 1.14
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.13
Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod (2006) 1.12
Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension (2012) 1.11
Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res (2010) 1.10
A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes (2009) 1.10
Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem (2003) 1.10
Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain. Hypertension (2012) 1.09
Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension (2007) 1.08
Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res (2004) 1.08
PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol (2012) 1.07
Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol (2011) 1.06
Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther (2009) 1.06
Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci (2012) 1.06
Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol (2008) 1.04
Reduction in the incidence of alveolar osteitis in patients treated with the SaliCept patch, containing Acemannan hydrogel. J Oral Maxillofac Surg (2002) 1.04
Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int (2010) 1.04
Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol (2008) 1.02
Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension (2005) 1.00
Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension (2010) 0.99
"Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol (2003) 0.99
Hemivertebra excision in children via simultaneous anterior and posterior exposures. J Pediatr Orthop (2004) 0.98
Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension (2010) 0.98
Cervical kyphosis associated with anteroposterior dissociation and quadriparesis in Larsen's syndrome. J Pediatr Orthop (2005) 0.98